Bearish flow noted in Relmada Therapeutics with 1,112 puts trading, or 1.3x expected. Most active are Nov-22 7.5 puts and Nov-22 5 puts, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 32.71, while ATM IV is up over 38 points on the day. Earnings are expected on November 10th.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RLMD:
- Rising High: Exclusive talk with financial services firm Safe Harbor
- Here’s What You Missed in Cannabis This Week
- Point72 Asset Management reports 7.3% passive stake in Relmada Therapeutics
- Axsome shares could react positively to Relmada trial failure, says BofA
- Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
